Extended nirmatrelvir-ritonavir for persistent COVID-19: Systematic review with individual patient data.

Paxlovid (nirmatrelvir/ritonavir) - Pfizer

http://www.ncbi.nlm.nih.gov/pubmed/41856461

Aresh Farokhnia; Jakob Nilsson; Johannes Eimer; Léon Kia Faro; Lukas Frischknecht; Tal Brosh-Nissimov; Yuan Tian

May 9, 2026